Journals / Türkiye Aile Hekimliği Dergisi / 2022 / Cilt: 26 - Sayı: 2

Compliance of Patients Using Warfarin to The Treatment and The Factors Affecting The Target INR

Varfarin Kullanan Hastaların Tedaviye Uyumu ve Hedef INR Değerini Etkileyen Faktörler

Pages
46–51
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The statistical significance level in the analysis was accepted as p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Our study aimed to examine the treatment compliance of patients using warfarin and investigate the effect of sociodemographic characteristics and treatment-related knowledge levels on the target INR value.
📊
Key Findings & Data:Descriptive statistics are presented as percentage, mean and standard deviation.
💡
Conclusion & Impact:The statistical significance level in the analysis was accepted as p
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Our study aimed to examine the treatment compliance of patients using warfarin and investigate the effect of sociodemographic characteristics and treatment-related knowledge levels on the target INR value. Method: It is a cross-sectional, descriptive study. In the study, three different questionnaire forms, namely Sociodemographic Information Form, Clinical Data Form, and Modified Morisky Scale (MMS), were used as data collection tools. Descriptive statistics are presented as percentage, mean and standard deviation. The normal distribution suitability of the variables was investigated using the Kolmogorov Smirnov Test. Chi-square test, Mann-Whitney U test, and t-test were used to compare data. The statistical significance level in the analysis was accepted as p

Özet

Amaç: Çalışmamızda, varfarin kullanan hastaların tedaviye uyumlarının incelenmesi, sosyodemografik özelliklerinin ve tedaviyle ilgili bilgi seviyelerinin hedef INR değerlerine etkilerinin araştırılması amaçlanmıştır. Yöntem: Kesitsel, tanımlayıcı nitelikte bir çalışmadır. Veri toplama aracı olarak Sosyodemografik Bilgi Formu, Klinik Veriler Formu ve Modifiye Morisky Ölçeği (MMÖ) olmak üzere üç anket formu kullanılmıştır. Verilerin karşılaştırılmasında ki-kare testi, Mann Withney U testi ve t testi kullanılmıştır. Analizlerde istatistiksel anlamlılık düzeyi p

🔖

Cite This Article

KENAN, E., KURTOĞLU, Y. K. (2022). Compliance of Patients Using Warfarin to The Treatment and The Factors Affecting The Target INR. Türkiye Aile Hekimliği Dergisi, Cilt: 26 - Sayı: 2, 46–51. https://ajindex.com/articles/626646

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Monagle P, Cuello CA, Augustine C, et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv 2018; 2(22): 3292- 3316
  2. Altunbas G, Ercan S, Davutoglu V. Overview of warfarin treatment and answers to questions/warfarin. Journal of Academic Emergency Medicine, 2013; 12(1): 38
  3. Burn J, Pirmohamed M. Direct oral anticoagulants versus warfarin: is new always better than the old? Open Heart 2018; 5(1): 1-4
  4. Lane DA, Lip GY. Maintaining therapeutic anticoagulation: the importance of keeping “within range”. Chest, 2007; 131(5): 1277-9
  5. Özcan T, Altıok M, Babalıklı F. The effect of group education about drug usage in the patient’s on warfarin therapy. The Anatolian Journal of Cardiology, 2013; 13(3): 292
  6. Wang M, Zeraatkar D, Obeda M, et al. Drug-drug interactions with warfarin: A systematic review and metaanalysis. Br J Clin Pharmacol 2021; 87(11): 4051-4100
  7. Ansell J, Hirsh J, Poller L., et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004; 126(3): 204-33
  8. Morisky DE, Gren LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67-74
  9. Vural B, Acar ÖT, Topsever P, ve ark. Modifiye Morisky ölçeğinin geçerlilik güvenilirlik çalışması. The Journal of Turkish Family Physician, 1999; 3: 17-20
  10. Çelik A, İzci S, Kobat MA. et al. WARFARİN-TR Study Collaborates. The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARİN TR. Anatol J Cardiol 2016; 16(8): 595-600
  11. Köksal AT, Avşar G. Oral antikoagülan ilaç kullanan hastalar antikoagülan tedavi ile ilgili ne biliyor ve ne yapıyor? Bir kardiyoloji servisindeki hastaların değerlendirilmesi. Balıkesir Saglık Bil Derg 2015; 4(3): 137-42
  12. Mariita K, Nyamu DG, Maina CK., et al. Patient factors impacting on oral anticoagulation therapy among adult outpatients in a Kenyan referral hospital. African Journal of Pharmacology and Therapeutics, 2016; 5(3): 193-200
  13. De Souza TF, Colet CF, Heineck I. Knowledge and information levels and adherence to oral anticoagulant therapy with warfarin in patients attending primary health care services. J Vasc Bras 2018; 17(2): 109-16
  14. Salem DN, Stein PD, Al-Ahmad A., et al. Antithrombotic therapy in valvular heart disease--native and prosthetic: the